October 2022

By releasing 21 CFR Part 11, the FDA indicated that digital tools aren’t just acceptable — they’re preferable

Adoption has been slower than predicted but the industry has made the advancements necessary to make pharmaceutical continuous manufacturing a reality

Pharma quality regulation has evolved beyond routine CGMP compliance toward a more holistic, proactive approach